Caris Life Sciences (CAI) is scheduled to announce Q3 earnings results on Wednesday, November 4th, after market close. The consensus EPS estimate is $0.02, and the consensus revenue estimate is ...

Mad Money' host Jim Cramer shares his favorite names in the life sciences space. Got a confidential news tip? We want to hear ...

ZS, a global management consulting and technology firm, today announced the expansion of agentic AI capabilities in ZAIDYN®, a connected suite of applications that combines advanced AI with ZS's more ...

MUV today announced it has completed the sale of its Meetings & Events division to miMeetings, the technology-forward event ground transportation company. The transaction allows MUV to concentrate ...

HONG KONG SAR - Media OutReach Newswire - 4 November 2026 - Sequencio Therapeutics Company Limited ("Sequencio"), a ...

Revvity, Inc. RVTY reported third-quarter 2026 adjusted earnings per share (EPS) of $1.38, up 16.9% year over year. The bottom line surpassed the Zacks Consensus Estimate of $1.29 by 7%. GAAP EPS from ...

Innovative Industrial Properties Q3 2026: life science expansion, leasing momentum and AFFO growth amid tenant risks.

The next major breakthrough in life sciences may have a company’s name attached to it, but increasingly, the story behind ...

Breaking news and analysis of biotech, life sciences and other emerging technologies and research impacting health and well-being.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

GT Metabolic Solutions has secured a Series C growth investment from J.P. Morgan Life Sciences Private Capital to accelerate ...

Cardiogenic shock, caused by heart attack or other heart issues, is associated with significant mortality despite advances in treatment. The VITALYST system is being developed to address the core ...